NT Cell Banking System for Immunocompatible Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current somatic cell nuclear transfer (SCNT) technologies face challenges in achieving high blastocyst formation rates due to zygotic gene activation and immune rejection issues, limiting their application in cell therapeutics for regenerative medicine.
Innovation Solution
A method involving screening for homozygosity in donor tissues, isolating nuclei from homozygous cells to generate immunocompatible NT cells, and cryopreserving these cells to create a banking system for stem cells that reduces immune rejection and enhances patient-specific treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If somatic cell nuclear transfer (SCNT) technology is used to generate patient-specific stem cells, then immune rejection response is inhibited, but the blastocyst formation rate remains low
Solution Approach 1:
The patent changes the genetic parameter of donor cells by selecting homozygous cells and inducing homozygosity through cell fusion or culture methods. This parameter change in the donor cells leads to homozygous NT cells that can form blastocysts at higher rates while maintaining immune rejection resistance, thus resolving the contradiction between reliability and productivity
Solution Approach 2:
The patent performs preliminary actions by screening donor cells for homozygosity before nuclear transfer, and by pre-inducing homozygosity in donor cells through fusion or culture methods. This preliminary preparation of homozygous donor cells enables subsequent NT cells to achieve both high blastocyst formation rates and immune rejection resistance
2Reliability
If zygotic gene activation is suppressed to improve blastocyst formation, then epigenetic barriers are reduced, but the complexity of the nuclear transfer process increases
Solution Approach 1:
The patent changes the epigenetic parameters of donor cells by inducing homozygosity and selecting specific genetic characteristics before nuclear transfer. This parameter change in donor cells simplifies the overall process by reducing epigenetic barriers during zygotic gene activation, thereby improving blastocyst formation success without significantly increasing process complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the generation of transplantable cells with reduced immune rejection risk, expanding the potential for treating diseases like diabetes and osteoarthritis by providing a banking system for immunocompatible stem cells.
Implementation Method 1
cryopreserving the stem cells
Data Source
AI summary
Provided are a storage method and a banking system of cells prepared using somatic cell nuclear transfer (NT) technology with homozygous genotypes of genes of human leukocyte antigen (HLA)-A, HLA-B, HLA-DR, and the like. The banking of NT cell-derived stem cells may be applied to autologous or allogenic patients and can provide transplantable cells and tissue materials for the treatment of various diseases such as diabetes, osteoarthritis, Parkinson's disease, and the like.